Cempra Poised To Join Antibacterial Drug Acquisition Rumor Buzz With Upcoming Data Release
Article By:
Scott Matusow
Read
Monday, November 24, 2014 12:28 PM EST
Cempra Pharmaceuticals expects top-line data release for community acquired bacterial pneumonia by the end of Q1'15.
With the very recent Tetraphase acquisition rumor buzz, Cempra is certain to join the acquisition buzz fray if its data release proves positive.
E Going Green And Saving Green
Article By:
Vivian Lewis
Read
Saturday, November 22, 2014 8:39 AM EST
Today we consider a way to play cheap fuel prices which directly offsets one of our oil plays. Plus, we plan to take the train. And we report on global energy, pharma and food stock happenings.
E Special Report: Benitec Biopharma Ltd.
Article By:
Vivian Lewis
Read
Thursday, November 20, 2014 8:41 AM EST
This special report is about Benitec, a stock we recommend, after I spent the morning at its US Investor Day.
In this article: BTEBY
AGIO Hits Record Level On Impressive Clinical Data For Leukemia Drug
Article By:
BioMedReports
Read
Thursday, November 20, 2014 3:21 AM EST
Shares of Agios Pharmaceuticals Inc. posted its biggest single day rally on Wednesday since 26th September. The stock is up a whopping 15% to $96.25 after hitting an all time high of $96.88 earlier in the session.
In this article: AGIO
E Merrimack Receives Fast Track For Pancreatic Cancer Drug
Article By:
Terry Chrisomalis
Read
Wednesday, November 19, 2014 4:29 PM EST
The reason the FDA gave MACK Fast Track approval is because there are no current therapies for pancreatic cancer -- the drug meets an unmet medical need.
Health Care REIT Completes HealthLease Transaction
Article By:
Business Wire
Read
Wednesday, November 19, 2014 12:00 PM EST
Health Care REIT, Inc. announced today the completion of the previously announced acquisition of HealthLease Properties REIT (“HealthLease”).
In this article: HCN
CytRx Announces Partial Clinical Hold On Main Drug' Big Buying Opportunity For Investors
Article By:
Terry Chrisomalis
Read
Tuesday, November 18, 2014 2:36 PM EST
Aldoxorubicin receives a partial clinical hold from the FDA.
In this article: CYTR
9 Insiders Purchase Shares Of Neptune On Open Market
Article By:
LastFinancier
Read
Tuesday, November 18, 2014 9:30 AM EST
9 insiders purchased shares of Neptune in the open market during the past week, including the Company’s interim CEO and new Chairman. With activist actions underway, can Neptune stock return to prior levels?
In this article: NEPT
Work Hard And Invest In The Future: Financial Review
Article By:
Marvin R Clark
Read
Monday, November 17, 2014 8:18 PM EST
If you thought the S&P’s furious 11% rally has been a sight to behold, you clearly weren’t paying attention to the soaring planes, trains and trucks.
E Celldex Therapeutics Surges 30% After Positive Phase 2 Data In Brain Cancer
Article By:
Terry Chrisomalis
Read
Monday, November 17, 2014 5:41 PM EST
Positive results in an interim phase 2 analysis of rindopepimut show increased survival.
In this article: CLDX